CAS: 1254205-52-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | RQ 00203078 REF: IN-DA009CK5CAS: 1254205-52-1 | % | 65.00 €~585.00 € | Wed 04 Dec 24 |
 | RQ-00203078 REF: TM-T2007CAS: 1254205-52-1 | 98% - 99.17% | 50.00 €~345.00 € | Wed 11 Dec 24 |
 | RQ-00203078 REF: 3D-FR137714CAS: 1254205-52-1 | Min. 95% | To inquire | Wed 15 Jan 25 |
RQ 00203078
CAS:1254205-52-1
Formula:
C21H13ClF6N2O5S
Purity:
%
Color and Shape:
Solid
Molecular weight:
554.8467
Ref: IN-DA009CK5
| 5mg | 65.00 € | ||
| 10mg | 84.00 € | ||
| 50mg | 164.00 € | ||
| 100mg | 259.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
RQ-00203078
CAS:1254205-52-1
RQ-00203078 is a highly selective, potent and orally available TRPM8 antagonist.
Formula:
C21H13ClF6N2O5S
Purity:
98% - 99.17%
Color and Shape:
Solid
Molecular weight:
554.85
Ref: TM-T2007
| 5mg | 50.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 121.00 € | ||
| 50mg | 183.00 € | ||
| 100mg | 345.00 € | ||
| 1mL*10mM (DMSO) | 58.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
RQ-00203078
CAS:1254205-52-1
RQ-00203078 is a CB2 receptor agonist that has been shown to inhibit the activity of …
Purity:
Min. 95%
Ref: 3D-FR137714
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
